(Q43559564)

English

Multiparameter immunophenotyping by flow cytometry in multiple myeloma: The diagnostic utility of defining ranges of normal antigenic expression in comparison to histology

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Multiparameter immunophenotyping by flow cytometry in multiple myeloma: The diagnostic utility of defining ranges of normal antigenic expression in comparison to histology (English)

1 reference

Europe PubMed Central

24 November 2017

1 reference

based on heuristic

inferred from title

author name string

Elisa Cannizzo

1

1 reference

Europe PubMed Central

24 November 2017

Emanuele Bellio

2

1 reference

Europe PubMed Central

24 November 2017

Aliyah R Sohani

3

1 reference

Europe PubMed Central

24 November 2017

Robert P Hasserjian

4

1 reference

Europe PubMed Central

24 November 2017

Judith A Ferry

5

1 reference

Europe PubMed Central

24 November 2017

Michelle E Dorn

6

1 reference

Europe PubMed Central

24 November 2017

Craig Sadowski

7

1 reference

Europe PubMed Central

24 November 2017

Janessa J Bucci

8

1 reference

Europe PubMed Central

24 November 2017

Giovanni Carulli

9

1 reference

Europe PubMed Central

24 November 2017

Frederic Preffer

10

1 reference

Europe PubMed Central

24 November 2017

publication date

1 July 2010

1 reference

Europe PubMed Central

24 November 2017

Cytometry Part B: Clinical Cytometry

1 reference

Europe PubMed Central

24 November 2017

78

1 reference

Europe PubMed Central

24 November 2017

4

1 reference

Europe PubMed Central

24 November 2017

231-238

1 reference

Europe PubMed Central

24 November 2017

describes a project that uses

1 reference

based on heuristic

inferred from title

C-kit ligand (SCF) in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

21 January 2018

Flow cytometry and the stability of phycoerythrin-tandem dye conjugates

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

21 January 2018

Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

21 January 2018

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

CD200 is a new prognostic factor in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypic characterization of the human myeloma cell growth fraction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional diagnostics in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical identification of HER-2/neu overexpression and CD117 (c-kit) expression in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-CD20 monoclonal antibody therapy in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy for immunoglobulin light chain amyloidosis: the new and the old.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Two cases of plasma cell leukemia with atypical immunophenotype

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of chemotherapy in the treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

CD20-Directed Serotherapy in Patients With Multiple Myeloma: Biologic Considerations and Therapeutic Applications

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab in CD20 positive multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

High expression of CD59 and CD55 on benign and malignant plasma cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of imatinib in patients with refractory/relapsed myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of CD36 (platelet glycoprotein IV) expression on platelets and monocytes by flow cytometry: application to the study of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20517

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CYTO.B.20517

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43559564&oldid=2100782683"